The Chronic Malignancies Working Party promotes and conduct educational activities and clinical investigations on haematopoietic stem cell transplantation in chronic haematological malignancies.
The CMWP consists of six subcommittees:
- PH1-negative MyeloProliferative Neoplasms (PH1-neg MPN)
- Chronic Myeloid Leukaemia (CML)
- Chronic Lymphocytic Leukaemia (CLL)
- Plasma Cell Disorders (PCD)
- Myelodysplastic Syndromes (MDS)
- Practice Harmonization and Guidelines (PHG)
Learn more about the CMWP
The mission of the CMWP is to contribute significantly to an improved outcome of stem cell transplantation in chronic haematological malignancies by:
- Performing high-quality retrospective registry studies
- Performing prospective clinical trials and non-interventional studies (NIS)
- Improving quality of data in collaboration with other WP and the registry committee
- Promoting advanced training and scientific interaction by performing “Educational Courses” and “Scientific Meetings”
- Collaboration with national and international Transplant – and Non-transplant (disease-specific) Groups
- Disseminating knowledge by up-to date information to the transplant and non-transplant scientific community, patient organisation and lay public.